Dopamine and glutamate in schizophrenia: biology, symptoms and treatment-Reference-Cited by-同舟云学术

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

Published:2020-01-10 Issue:1 Volume:19 Page:15-33
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

McCutcheon Robert A.¹²³,Krystal John H.⁴⁵⁶,Howes Oliver D.¹²³

Affiliation:

1. Institute of Psychiatry, Psychology and NeuroscienceKing's College London London UK

2. MRC London Institute of Medical Sciences, Imperial College LondonHammersmith Hospital London UK

3. South London and Maudsley Foundation NHS TrustMaudsley Hospital London UK

4. Department of Radiology and Biomedical ImagingYale University School of Medicine New Haven CT USA

5. Department of PsychiatryYale University School of Medicine New Haven CT USA

6. VA National Center for PTSDVA Connecticut Healthcare System West Haven CT USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Phychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wps.20693

Reference267 articles.

1. Schizophrenia: an overview;McCutcheon RA;JAMA Psychiatry

2. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis

3. The significance of dopamine‐receptor blockade for the mechanism of action of neuroleptic drugs;Rossum JM;Arch Int Pharmacodyn Thérapie,1966

4. Antipsychotics: mechanisms underlying clinical response and side‐effects and novel treatment approaches based on pathophysiology;Kaar SJ;Neuropharmacology

5. 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of acute and chronic ketamine administration on spontaneous and evoked brain activity;Brain Research;2025-01

2. Psychosis and Schizophrenia;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

3. Dopaminergic system and neurons: Role in multiple neurological diseases;Neuropharmacology;2024-12

4. GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases;Pharmacological Research;2024-10

5. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data;Schizophrenia Research;2024-10